Cytokinetics Q3 Earnings Preview Includes EPS Estimate
Cytokinetics is scheduled to report Q3'26 results on Nov. 4 after market close. Revenue and EPS estimates were provided ahead of the report.
Related stories
Nasdaq single-stock trading halt continues, symbol not given — reason not given (9:30 AM ET)
Nasdaq kept trading halted in a single listed security (reason not given) at 9:30 AM ET.
M impact | EQUITY | Nov 03, 2026, 02:46 PM UTC
EEE: trading halted on Nasdaq — volatility pause (9:30 AM ET)
Nasdaq halted trading in EEE (volatility pause) at 9:30 AM ET.
M impact | EQUITY | Nov 03, 2026, 02:40 PM UTC
General Electric Aerospace Shares Hit 5-week High
General Electric Aerospace shares increased to 321.44 USD, the highest since September 2026. Over the past 4 weeks, General Electric Aerospace gained 4.03%, and in the last 12 mont
L impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Palantir Shares Hit Over One-Month Low, Down 6.2%
Palantir Technologies shares hit an over one-month low after Q3 results and were last down 6.2%.
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
IWG Reports Third-Quarter Revenue Growth, Shares Rally
System-wide revenue rose 12% to $1.26 billion and group revenue increased 9% to $1.03 billion in the three months to September end.
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Shopify shares fall 10% after quarterly results
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC